What is the ticker symbol for Neurogene?

Neurogene trades under the ticker NGNE on NASDAQ.

What sector does Neurogene operate in?

Neurogene is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze NGNE in a portfolio?

PortView shows NGNE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Neurogene (NGNE) Stock Analysis

NASDAQHealthcareBiotechnology

$37.17-1.85%

1-year price historyRange $16.37 – $42.84

52-week range$37.17

$15.93$43.66

What Neurogene does

Neurogene Inc. is dedicated to engineering transformative genetic treatments for individuals and their families grappling with debilitating neurological conditions. Its current pipeline prominently features two key investigational therapies: NGN-401, an AAV9 gene therapy specifically targeting Rett syndrome, and NGN-101, which is being developed to address neuronal ceroid lipofuscinosis subtype 5 (Batten disease). The company's operations are based in New York, New York.

Key metrics

Market cap

$587.37M

P/E (TTM)

-8.17

EPS (TTM)

$-4.55

Beta

1.95

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$35.94

200-day avg

$25.92

52-week high

$43.66

52-week low

$15.93

CEO

Rachel L. McMinn

ETFs linked to NGNE

Broad-market and Healthcare sector ETFs an investor holding Neurogene is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how NGNE fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NGNE in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Neurogene?: Neurogene trades under the ticker NGNE on NASDAQ.
Which exchange is NGNE listed on?: NGNE is listed on NASDAQ.
What sector does Neurogene operate in?: Neurogene is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze NGNE in a portfolio?: PortView shows NGNE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.